Scholar Rock Holding Corporation
SRRK
Classement en actions
#3309
Scholar Rock Holding Corporation is a biopharmaceutical firm dedicated to... Scholar Rock Holding Corporation is a biopharmaceutical firm dedicated to discovering and advancing treatments for severe medical conditions by targeting the crucial role of protein growth factor signaling. Their lead therapeutic candidate, Apitegromab, an agent designed to inhibit the activation of latent myostatin, has successfully concluded Phase 3 clinical trials for spinal muscular atrophy (SMA). Another key program, SRK-181, is currently undergoing Phase 1 clinical assessment for tackling cancers that exhibit resistance to established checkpoint inhibitor treatments, including anti-PD-1 or anti-PD-L1 antibody therapies. Beyond these, the company cultivates a robust pipeline of innovative potential therapies, aiming to significantly improve the lives of individuals grappling with various severe ailments, such as neurological muscle conditions, malignancies, and fibrotic disorders. In a strategic partnership, Scholar Rock is collaborating with Gilead Sciences, Inc. to identify and develop targeted inhibitors of transforming growth factor beta (TGF-beta) activation, specifically for addressing fibrotic diseases. Established in 2012, Scholar Rock Holding Corporation operates from its headquarters in Cambridge, Massachusetts.
Prix de l'action
$42.53
Capitalisation boursière
$5.18B
Changement (1 jour)
-1.09%
Changement (1 an)
49.14%
Pays
US
Échange Scholar Rock Holding Corporation (SRRK)
Catégorie
Healthcare
Historique du prix de l'action pour Scholar Rock Holding Corporation (SRRK)
Prix de clôture le plus élevé : $42.20 le 2026-10-01
Prix de clôture le plus bas : $16.12 le 2018-05-01
Prix de clôture le plus bas : $16.12 le 2018-05-01
Historique du prix de l'action de Scholar Rock Holding Corporation de 2018 à 2026
Performance annuelle du prix de l'action
| Année | Performance |
|---|---|
| 2026 (TTM) | 3.65% |
| 2025 | 4.21% |
| 2024 | 139.27% |
| 2023 | 123.69% |
| 2022 | -68.52% |
| 2021 | -46.82% |
| 2020 | 347.42% |
| 2019 | -54.48% |
| 2018 | 0.00% |
Prix de l'action pour des entreprises similaires ou concurrentes
| Entreprise | Prix de l'action | Variation 1a% | Pays |
|---|---|---|---|
| $523.31 | 22.71% |
US
|
|
| $237.47 | 784.43% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $874.99 | 7.47% |
NL
|
|
| $287.83 | 1.13% |
BE
|
